Protein deficiency impairs DNA vaccine-induced antigen-specific T cell but not B cell response in C57BL/6 mice.
DNA vaccination is a simple method to induce antigen (Ag)-specific immunoresponse and has many potential advantages over other vaccines. Although people who need to receive vaccines often suffer undernutrition, there has been no study on a how nutritional status affects the immunoresponse induced by DNA vaccination. The aim of this study was to determine the relationship between protein deficiency and DNA vaccine-induced immunoresponses. C57BL/6 mice were fed a 5% or 20% casein diet for 30 d. The mice were immunized with an ovalubumin (OVA)-expression plasmid by the gene gun-based method three times at 10-d intervals. Body weight and serum albumin concentration in protein-deficient mice were significantly lower than those in mice fed the 20% casein diet (p<0.01, p<0.05). The percentage of OVA-specific CD8+ T cells was significantly decreased in the 5% casein group compared to that in the 20% casein group (p<0.05). Furthermore, CD4+ T cells from mice fed the low-protein diet showed lower interleukin (IL)-2 production than did those from the 20% group. In contrast to the T-cell function, protein deficiency did not affect OVA-specific Ab responses (p>0.05). These results suggest that protein deficiency impairs the induction of Ag-specific T-cell but not B-cell response in DNA-immunized mice. Our observation indicates that, in addition to development of an effective of DNA vaccine, the management of nutritional state is important for the prevention of infectious disease by DNA vaccination.
Sakai
Tohru
T
Department of International Nutrition, Institution of Health Bioscience, The University of Tokushima Graduate School, Kuramnoto 3-18-15, Tokushirna 770-8503, Japan. tohrus@nutr.med.tokushima-u.ac.jp
Mitsuya
Kaori
K
Kogiso
Mari
M
Ono
Kaori
K
Komatsu
Tatsushi
T
Yamamoto
Shigeru
S
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology*; D001835:Body Weight / Q000187:drug effects; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D002364:Caseins / Q000008:administration & dosage; D004195:Disease Models, Animal; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D005434:Flow Cytometry / Q000379:methods; D007074:Immunoglobulin G / Q000097:blood; D007376:Interleukin-2 / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D011488:Protein Deficiency / Q000150:complications* / Q000276:immunology; D011947:Receptors, Antigen, B-Cell / Q000187:drug effects / Q000276:immunology*; D011948:Receptors, Antigen, T-Cell / Q000187:drug effects / Q000276:immunology*; D012709:Serum Albumin / Q000187:drug effects; D013154:Spleen / Q000187:drug effects / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D019444:Vaccines, DNA / Q000494:pharmacology*
D002364:Caseins; D007074:Immunoglobulin G; D007376:Interleukin-2; D011947:Receptors, Antigen, B-Cell; D011948:Receptors, Antigen, T-Cell; D012709:Serum Albumin; D019444:Vaccines, DNA